Medial medullary syndrome
Medial Medullary Syndrome (also known as Dejerine Syndrome) is a type of stroke that affects the medulla oblongata, a part of the brainstem. This condition is typically caused by a blockage in the anterior spinal artery, which supplies blood to the medulla.
Symptoms[edit | edit source]
The symptoms of Medial Medullary Syndrome can vary depending on the severity and location of the stroke. Common symptoms include:
- Weakness or paralysis on one side of the body (hemiparesis)
- Difficulty speaking or swallowing (dysarthria and dysphagia)
- Loss of sensation on the opposite side of the body
- Vertigo or dizziness
- Nystagmus, an involuntary movement of the eyes
Causes[edit | edit source]
The primary cause of Medial Medullary Syndrome is a blockage in the anterior spinal artery. This can occur due to a variety of reasons, including:
- Atherosclerosis, a condition where the arteries become narrow due to the buildup of plaque
- Blood clots
- Inflammation of the blood vessels (vasculitis)
- Diabetes
- High blood pressure
Diagnosis[edit | edit source]
Diagnosis of Medial Medullary Syndrome is typically made based on the patient's symptoms and medical history. Imaging tests such as a CT scan or MRI may be used to confirm the diagnosis and determine the extent of the stroke.
Treatment[edit | edit source]
Treatment for Medial Medullary Syndrome focuses on managing the symptoms and preventing further strokes. This may include:
- Medications to control blood pressure and cholesterol levels
- Anticoagulants to prevent blood clots
- Physical therapy to help with mobility and strength
- Speech therapy to help with speech and swallowing difficulties
Prognosis[edit | edit source]
The prognosis for Medial Medullary Syndrome can vary greatly depending on the severity of the stroke and the patient's overall health. Some people may make a full recovery, while others may have long-term or permanent disabilities.
See also[edit | edit source]
Medial medullary syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD